Insider buying last 90 days
No open-market insider purchases were filed for HLF in the last 90 days.
From Form 4 filings, dated to when each was filed.
Oct 12 close
Herbalife's week includes news that Scott Schaefer, SVP of Finance and Transformation and incoming CFO, will attend one-on-one meetings at the Maxim Growth Summit in New York on 14 October, alongside the company's participation announcement dated 5 October. The stock itself moved up 4.5% this week, a shift not directly tied to that meeting announcement but occurring alongside it.
HLF closes at $13.61, sitting between its 50-day average of $12.28 and 200-day average of $14.03, reflecting a mixed trend picture. The GekkoIndex reads 45.8, placing it in the Neutral zone, down from a five-day change of -9.8. Price sits 36.1% below Gekko Fair Value of $21.29. Over the past year the stock has returned 50.9%, though the six-month return is -12.4%, with 52-week range spanning $7.56 to $20.40.
Earnings are scheduled for 2 November, after close, 21 days away and falling inside a typical 20-trading-day holding window; the prior report on 5 August saw EPS of $0.51 against a $0.63 estimate, with a -10.1% reaction, part of a record of 6 beats in 8 quarters and average absolute reactions of 15.2%. Seasonality over this calendar stretch has averaged -0.3% across 5 years, rising in 2 of them. No insider, Congress or unusual options activity appears in the respective windows. Analyst consensus from 4 firms includes 3 buy and 1 sell ratings, with a consensus target of $17 and 24.9% upside cited.
Written by AI from the Oct 12, 2026 close and checked automatically against the figures on this page.
Herbalife scores 1 supportive, 2 mixed and 2 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
1 supportive2 mixed2 headwinds
Averages disagree
Close $13.61 sits between the 50-day ($12.28) and 200-day ($14.03) averages, or the averages disagree.
See the chart45.8, Neutral
Reading 45.8 is in the Neutral zone.
See the GekkoIndex36.1% below
Price is 36.1% below Gekko Fair Value (more than 5% below).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 21 days
Reports on Nov 2, 2026, 21 days away — inside a typical 20-trading-day hold.
See earnings−0.3% on average
From this point in the calendar, the next 20 trading days averaged −0.3% over 5 years, rising in 2 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Herbalife closed at $13.61 on Oct 12, 2026, +50.9% over the past year, inside a 52-week range of $7.56 to $20.40.
Use the left and right arrow keys to read daily values.
Put HLF on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Herbalife makes and markets nutrition products, with offerings grouped around weight management, targeted dietary supplements, outer personal care, and energy and sports nutrition. Its lineup includes meal replacement shakes, powdered drink mixes, weight-loss aids and snacks, supplements built from herbs, vitamins and minerals, skin and hair care items, and energy products such as N-R-G tea. The business operates across North America, Mexico, Central and South America, Europe, the Middle East, Africa, China and the wider Asia Pacific region.
Beyond its products, the company supplies the materials that support its sales network, including starter kits, promotional tools and training content. Rather than selling mainly through its own stores, it reaches customers chiefly through independent service providers and sales representatives, supplemented by some company-run retail outlets.
The business traces back to a 1980 founding in Los Angeles, California, and operated as Herbalife Ltd. before adopting the Herbalife Nutrition name in April 2018. Its shares are listed on the NYSE under the ticker HLF.
Herbalife’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 45.8, in the Neutral zone, down 9.8 points over five sessions.
Down 9.8 points over five sessions.
Reading for Oct 12, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 73 | +3.1% | +9.7% | ||
| Accumulation | 229 | +0.2% | +2.2% | ||
| Neutral (current zone) | 336 | +0.4% | +0.1% | ||
| Distribution | 41 | −1.7% | −2.7% | ||
| Selling | 3 | Too few readings yet | |||
Average HLF share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.1% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
Herbalife trades 36.1% below Gekko Fair Value of $21.29, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Herbalife shares are worth, recalculated every trading day.
$21.29
Gekko Fair Value, Oct 10, 2026
36.1% Undervalued
At the end of Aug 2026 the price was 28.5% below the estimate.
No open-market insider purchases were filed for Herbalife, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for HLF in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in HLF were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Herbalife has been buying back its own shares.
From company filings.
2of the funds Gekko tracks hold HLF.
Herbalife reports on Nov 2, 2026, after the close (21 days away), and beat the EPS estimate in 6 of its last 8 reports.
Nov 2, 2026
Expected after the close, 21 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 5, 2026 | $0.51 est $0.63 | $1.33B est $1.31B | −10.1% |
| May 6, 2026 | $0.64 est $0.61 | $1.32B est $1.30B | −10.9% |
| Feb 18, 2026 | $0.45 est $0.48 | $1.28B est $1.24B | +22.8% |
| Nov 5, 2025 | $0.50 est $0.47 | $1.27B est $1.25B | +15.3% |
| Aug 6, 2025 | $0.59 est $0.50 | $1.26B est $1.25B | −8.9% |
| Apr 30, 2025 | $0.59 est $0.41 | $1.22B est $1.23B | −6.2% |
| Feb 19, 2025 | $0.36 est $0.09 | $1.21B est $1.19B | +38.5% |
| Oct 30, 2024 | $0.57 est $0.35 | $1.24B est $1.25B | +8.5% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Herbalife is $17.00, +24.9% from the last close, from 4 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 4 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 17 | Texas Capital Securities | $21 | +54.3% |
| Sep 1 | Maxim Group | $25 | +83.7% |
| Aug 31 | Bank of America Securities | $9 | −33.9% |
| Aug 7 | Citi | $17 | +24.9% |
| Aug 6 | Bank of America Securities | $9 | −33.9% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Oct 10, Herbalife averaged −0.3% across the last 5 years, rising in 2 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +3.6% | 4 of 5 |
| Next 10 trading days | +1.8% | 3 of 5 |
| Next 15 trading days | +0.6% | 3 of 5 |
| Next 20 trading days | −0.3% | 2 of 5 |
| Next 30 trading days | +4.3% | 2 of 5 |
For scale, HLF’s typical 20-trading-day move in either direction is about 11.8%.
Herbalife’s market cap is $1.41B, with a P/E ratio of 8.2 and revenue of $5.20B over the last twelve months.
1 headline about Herbalife from the past week, newest first, each linking to the publisher.
Herbalife’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| KHCKraft Heinz | Accumulation | 1.7% below |
| GISGeneral Mills | Accumulation | 31.1% below |
| CAGConAgra Brands | Accumulation | 6.6% below |
| SMPLSimply Good Foods | Neutral | 44.0% below |
| BGSB&G Foods | Accumulation | 54.4% below |
| BYNDBeyond Meat | Buying | 40.5% below |
A peer links to its own page where one exists.
Herbalife’s market cap is $1.41B at the Oct 12, 2026 close of $13.61, with 104.8M shares outstanding. The shares trade on a P/E ratio of 8.2.
The consensus analyst 12-month price target for Herbalife is $17.00, +24.9% from the last close. Of the 4 firms that rated the stock in the last 90 days, 3 rate it a buy, 0 a hold and 1 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Herbalife is undervalued: the Oct 12, 2026 close of $13.61 is 36.1% below Gekko Fair Value of $21.29. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Herbalife is expected to report on Nov 2, 2026, after the market closes (21 days away). Analysts expect earnings of $0.62 per share on revenue of $1.31B. Herbalife beat the earnings estimate in 6 of its last 8 reports, moving 15.2% on average across the report.
Herbalife’s 52-week high is $20.40 and its 52-week low is $7.56; it closed at $13.61 on Oct 12, 2026, +50.9% over the past year. Over the last five years the shares peaked at $47.86 on Oct 25, 2021.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 1 of the 5 items with data read as supportive (fair value), 2 as mixed (trend and gekkoindex) and 2 as headwinds (earnings risk and seasonality). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,408 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.